Yahoo! Finance
03-17-2009, 09:30 AM
<b>Yahoo! Finance: Mutual Fund News</b>
PharmaNet Development Group, Inc. , a leading provider of clinical development services to innovative pharmaceutical, biotechnology, generic drug and medical device companies, announced that, pursuant to the terms of the indenture governing its 2.25% convertible senior notes due 2024 , it anticipates that a "Fundamental Change" may occur as early as March 20, 2009, subject to the satisfaction or waiver of a number of conditions .
complete story here... (http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/090317/ph84755.html?.v=1)
PharmaNet Development Group, Inc. , a leading provider of clinical development services to innovative pharmaceutical, biotechnology, generic drug and medical device companies, announced that, pursuant to the terms of the indenture governing its 2.25% convertible senior notes due 2024 , it anticipates that a "Fundamental Change" may occur as early as March 20, 2009, subject to the satisfaction or waiver of a number of conditions .
complete story here... (http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/090317/ph84755.html?.v=1)